announced Tuesday that it has reached an exclusive licensing agreement with Chinese biotech MabCare Therapeutics to obtain rights for an experimental cancer therapy. The subject of the agreement ...

Taysha Gene Therapies has unfurled more data in the developmental disorder Rett syndrome, linking its gene therapy to improvements ... Taysha’s second adult patient, a 21-year-old female ...

The risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared last year, an FDA official said June 14 at cell and gene therapy conference in King of Prussia.

HealthDay News — Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England Journal of Medicine.

Here's how things could shake out for Musk under a second Trump administration versus a Joe Biden win.

While Musk is increasingly flexing his political power, whoever wins the White House could drastically impact the billionaire and his businesses. Here's how things could shake out for Musk under a ...

After seeing new Las Vegas Raiders' quarterback Gardner Minshew take the majority of the snaps on Tuesday, second-year quarterback ... to maximize their reps to gain the upper hand and some ...

Here's how things could shake out for Musk under a second Trump administration versus a Joe Biden win. Musk under Trump Musk previously served on business advisory groups under the first Trump ...

Play video UK can do better than Johnson's 'botched' post-Brexit trade deal - Starmer from BBC ...

The risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared last year, an FDA official said Friday at cell and gene therapy conference in King of Prussia. The ...

With Hodge in the lineup, Colorado's secondary gains much-needed experience and versatility. His ability to replicate his Liberty form could transform the Buffs' defense into one of the Big-12’s ...

FRIDAY, June 14, 2024 (HealthDay News) -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England ...